Skip to main content
. 2015 Apr 10;35(2):156–164. doi: 10.1007/s40846-015-0032-9

Fig. 7.

Fig. 7

Tumor volume growth curves for treatment with non-targeting MBs, targeting MBs, and targeting MBs combined with pUS treatment. Targeting MBs after pUS treatment showed statistically significant growth suppression compared to all other groups (p < 0.05). Tumor growth of targeting MB treatment group was mildly suppressed compared to that of non-targeting MBs, but this difference was still statistically significant (p < 0.05)